Home » Topics » Medical technology

Medical technology
RSS

Other News To Note

May 25, 2007

Sunesis Raises $21M Publicly To Advance Cancer Trials

May 25, 2007

By Trista Morrison

Pivotal PolyHeme Trial Fails To Hit Endpoints, Hurting Northfield

May 24, 2007

By Aaron Lorenzo

Sirtris Increases Shares, Raises $60M In IPO For Sirtuin Work

May 24, 2007

By Jennifer Boggs

NewCo News: Arete Completes $51M Round For New Hypertension Class

May 24, 2007

Vion Halts Phase III AML Trial, Causing Stock Drop

May 24, 2007

By Aaron Lorenzo

Cypress Shares Soar On Positive Phase III Data In Fibromyalgia

May 24, 2007

By Trista Morrison

Public Offering Generates $163M In Cash For Advanced Magnetics

May 24, 2007

By Jennifer Boggs

Awaiting results from the final of four pivotal studies of its iron replacement therapeutic ferumoxytol, Cambridge, Mass.-based Advanced Magnetics Inc. is raising $162.9 million. (BioWorld Today)

Clinic Roundup

May 24, 2007

U.S. Patent Disclosures

May 24, 2007

Popular Stories

Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
AA meeting of minds as PTC, Novartis push votoplam in HD
BioWorld
What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...
Innervation can slow, as well as speed, tumor growth, study finds
BioWorld
Innervation by the sympathetic nervous system is typically a boon to tumors. But researchers from Weill Cornell Medicine and colleagues have shown that in some...
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...